Your browser doesn't support javascript.
loading
Transfusion-associated circulatory overload in gastroenterology.
Piccin, Andrea; Spizzo, Gilbert; Popovski, Mark A; Russo, Francesco P; Armanaschi, Luca; Vecchiato, Cinzia; Frena, Antonio; Mega, Andrea.
Afiliação
  • Piccin A; Department of Haematology and Oncology, Innsbruck Medical University, Innsbruck, Austria.
  • Spizzo G; Department of Haematology Oncology, Children's Health Ireland at Crumlin, Dublin, Ireland.
  • Popovski MA; Faculty of Medicine, University of Trento, Trento, Italy.
  • Russo FP; Department of Haematology and Oncology, Innsbruck Medical University, Innsbruck, Austria.
  • Armanaschi L; Department of Gastroenterology, "San Maurizio" Regional Hospital, Bolzano, South Tyrol, Italy.
  • Vecchiato C; Transfusion Department, Harvard University of Medicine, Boston, United States of America.
  • Frena A; Department of Oncology Surgery, Section Gastroenterology, University of Padova, Padua, Italy.
  • Mega A; Administrative Department, "San Maurizio" Regional Hospital, Bolzano, South Tyrol, Italy.
Blood Transfus ; 19(3): 197-204, 2021 May.
Article em En | MEDLINE | ID: mdl-33000753
ABSTRACT

BACKGROUND:

Transfusion-associated circulatory overload (TACO) is a rare life-threatening event associated with transfusion. This study aimed to identify any case of TACO in a large cohort of highly transfused patients with gastrointestinal tract (GI) bleeding. MATERIALS AND

METHODS:

Data from patients who underwent an oesophago-gastro-duodenoscopy (OGD) were collected over one year from the gastroenterology service of a regional hospital.

RESULTS:

A total of 278 patients were identified, of which 81 required transfusion. In total, 811 blood components were transfused (red cell concentrate, platelets, plasma), leading to a cumulative TACO incidence of 12.3%. The probability of developing TACO was greater for patients aged ≥80 years (OR=3.9%; p=0.0058), with renal disease (OR=1.9%, p=not significant) and with cardiac disease (OR 11.1%; p=0.003). Patients with TACO had a lower overall survival (52 vs 20% at 3 years, p=0.034, HR=2.19, 95% CI 1.04-4.63) compared to patients with cirrhosis without TACO (57 vs 28% at 3 years, p=0.003, HR=2.20, 95% CI 1.30-3.72). Patients with an advanced stage of liver cirrhosis (Child Pugh c10 or more) were most likely to develop TACO.

DISCUSSION:

This study shows that within the GI setting TACO may be markedly under-reported. Clinical awareness for potential TACO development in GI patients with cardiac or renal disease or age >80 years is now required.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article